Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Nexfarma Oy
OY
Active
Y-tunnus 2638617-5
Pl 42, 00701
Helsinki
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2014
— employees
www.nutrielixir.fi
Watchlist
Share
Finland
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Nexfarma Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
1M
1M
1M
1M
2021
1M
2022
1M
2023
1M
2024
0M
2025
EBITDA
EUR millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
EUR thousands
Item
2021
2022
2023
2024
2025
Revenue
520
606
696
759
0
Staff expenses
−20
−14
−17
−17
−0
EBITDA
49
−18
27
67
0
Depreciation & amort.
—
−1
−2
−2
−0
EBIT
49
−19
25
66
0
Net financials
−20
−17
−51
−59
0
Profit before tax
29
−36
−26
6
0
Tax
6
−0
−0
−0
−0
Net profit
23
−36
−26
6
0
Balance sheet
EUR thousands
Item
2021
2022
2023
2024
2025
Total assets
177
226
224
263
0
Equity
54
18
−8
−2
0
Long-term debt
—
—
8
71
0
Short-term debt
123
209
224
194
0
Total debt
123
209
232
265
0
Financial ratios
5-year trend
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
2021
2025
Equity ratio
0.0%
This company
38.2%
Market median
-100% vs market
2021
2025
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
2021
2025
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
2021
2025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2021
2025
Debt / equity
-1.00×
This company
0.62×
Market median
+261% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
More on Nexfarma Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
